For the Inventor, By the Inventor

Enter assignee name

Munich, Germany

Icon Genetics Gmbh

USPTO Granted Patents = 35

CIPO Patents = 5

EPO Patents = 26

Forward Citations = 49

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Yuri Gleba (25 out of 33 patents)

Victor Klimyuk (23 out of 27 patents)

Sylvestre Marillonnet (17 out of 22 patents)

4. Stefan Werner (11 out of 14 patents)

5. Carola Engler (6 out of 7 patents)

6. Romy Kandzia (4 out of 6 patents)

7. Frank Thieme (4 out of 6 patents)

8. Serik Eliby (4 out of 6 patents)

9. Yurii Dorokhov (4 out of 4 patents)

10. Peter Ivanov (4 out of 5 patents)

11. Franziska Jarczowski (3 out of 4 patents)

12. Koen Weterings (3 out of 3 patents)

13. Anatoly Giritch (3 out of 6 patents)

14. Joseph Atabekov (3 out of 3 patents)

15. Maxim Vladimirovich Skulachev (3 out of 21 patents)

35 patents: Sort by Forward Citations

1. 11633467 - Immunogenic composition and vaccine for generating an immune response to norovirus (2023-04-25),

2. 11597937 - System and method of modular cloning (2023-03-07),

3. 10435704 - Method of co-expressing a glycoprotein and a single-subunit olicosaccharyltransferase in a plant (2019-10-08),

4. 10287602 - RNA virus-derived plant expression system (2019-05-14),

5. 10196664 - [object Object] (2019-02-05),

6. 10052370 - HER2/Neu cancer vaccine (2018-08-21),

7. 9267143 - RNA virus-derived plant expression system (2016-02-23),

8. 9181532 - Production of galactosylated N-glycans in plants (2015-11-10),

9. 8940963 - Production of hetero-oligomeric proteins in plants (2015-01-27),

10. 8933297 - [object Object] (2015-01-13),

11. 8883420 - Process of clean cloning (2014-11-11),

12. 8624080 - Plant virus-based inducible expression system (2014-01-07),

13. 8415463 - Potexvirus-derived replicon (2013-04-09),

14. 8257945 - Identification of eukaryotic internal ribosome entry site (IRES) elements (2012-09-04),

15. 8193410 - Transgenic plants with controlled distribution of a trait to progeny (2012-06-05),

Icon Genetics GmbH is a biotechnology company specializing in plant-based biopharmaceutical production. With expertise in molecular biology, plant transformation, and bioprocessing, Icon Genetics offers innovative solutions for the development and manufacturing of therapeutic proteins, antibodies, vaccines, and other biologics. By using their proprietary magnICON technology, the company enables cost-effective and scalable production of high-quality biologics in plants. Icon Genetics aims to contribute to the advancement of healthcare by providing efficient and sustainable biopharmaceutical production methods.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

35 Patents

#87 in W-8000 Munich

#1,460 in Germany

#18,611 in the World

Munich, Germany

Icon Genetics Gmbh

Forward Citations = 49

43 inventors:

Yuri Gleba (25 out of 33 patents)

Victor Klimyuk (23 out of 27 patents)

Sylvestre Marillonnet (17 out of 22 patents)

4. Stefan Werner (11 out of 14 patents)

5. Carola Engler (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…